Anchor Capital Advisors LLC decreased its position in shares of Varian Medical Systems, Inc. (NYSE:VAR) by 99.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,411 shares of the medical equipment provider’s stock after selling 432,156 shares during the period. Anchor Capital Advisors LLC’s holdings in Varian Medical Systems were worth $352,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. First Mercantile Trust Co. raised its stake in shares of Varian Medical Systems by 2.3% in the first quarter. First Mercantile Trust Co. now owns 1,093 shares of the medical equipment provider’s stock worth $100,000 after buying an additional 25 shares in the last quarter. Parallel Advisors LLC raised its stake in Varian Medical Systems by 16.7% in the first quarter. Parallel Advisors LLC now owns 1,232 shares of the medical equipment provider’s stock worth $113,000 after buying an additional 176 shares during the period. Heritage Trust Co acquired a new stake in Varian Medical Systems during the first quarter worth $118,000. Penserra Capital Management LLC raised its stake in Varian Medical Systems by 9.5% in the first quarter. Penserra Capital Management LLC now owns 1,610 shares of the medical equipment provider’s stock worth $146,000 after buying an additional 140 shares during the period. Finally, Pacer Advisors Inc. raised its stake in Varian Medical Systems by 3.1% in the first quarter. Pacer Advisors Inc. now owns 1,815 shares of the medical equipment provider’s stock worth $165,000 after buying an additional 55 shares during the period. 99.27% of the stock is owned by hedge funds and other institutional investors.

Varian Medical Systems, Inc. (NYSE VAR) opened at 96.48 on Tuesday. The company has a market capitalization of $8.85 billion, a P/E ratio of 31.76 and a beta of 0.61. The firm has a 50-day moving average of $103.21 and a 200-day moving average of $92.66. Varian Medical Systems, Inc. has a one year low of $75.20 and a one year high of $107.08.

Varian Medical Systems (NYSE:VAR) last announced its earnings results on Wednesday, July 26th. The medical equipment provider reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $0.95 by $0.09. Varian Medical Systems had a return on equity of 24.70% and a net margin of 9.50%. The company had revenue of $662.40 million during the quarter, compared to analysts’ expectations of $663.86 million. During the same period last year, the business posted $1.00 EPS. Varian Medical Systems’s revenue for the quarter was up 3.0% on a year-over-year basis. On average, analysts anticipate that Varian Medical Systems, Inc. will post $3.95 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This report was originally published by Daily Political and is owned by of Daily Political. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://www.dailypolitical.com/2017/08/08/varian-medical-systems-inc-var-position-lowered-by-anchor-capital-advisors-llc.html.

A number of analysts recently weighed in on VAR shares. BTIG Research raised shares of Varian Medical Systems from a “neutral” rating to a “buy” rating and set a $106.00 price objective for the company in a research note on Monday, May 8th. BidaskClub lowered shares of Varian Medical Systems from a “strong-buy” rating to a “buy” rating in a research note on Thursday, June 29th. Citigroup Inc. raised shares of Varian Medical Systems from a “neutral” rating to a “buy” rating in a research note on Monday, May 15th. Aegis reaffirmed a “hold” rating and issued a $91.00 price objective on shares of Varian Medical Systems in a research note on Wednesday, May 17th. Finally, Goldman Sachs Group, Inc. (The) started coverage on shares of Varian Medical Systems in a research note on Tuesday, May 16th. They issued a “neutral” rating and a $92.00 price objective for the company. Three investment analysts have rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $96.28.

In other news, Director Mark R. Laret sold 1,428 shares of Varian Medical Systems stock in a transaction dated Thursday, June 8th. The stock was sold at an average price of $103.47, for a total value of $147,755.16. Following the completion of the transaction, the director now owns 3,289 shares in the company, valued at approximately $340,312.83. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Dow R. Wilson sold 15,060 shares of Varian Medical Systems stock in a transaction dated Monday, July 10th. The shares were sold at an average price of $103.37, for a total value of $1,556,752.20. Following the completion of the transaction, the insider now owns 81,836 shares of the company’s stock, valued at approximately $8,459,387.32. The disclosure for this sale can be found here. Insiders sold a total of 144,087 shares of company stock valued at $14,652,328 in the last quarter. Company insiders own 0.91% of the company’s stock.

About Varian Medical Systems

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Want to see what other hedge funds are holding VAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varian Medical Systems, Inc. (NYSE:VAR).

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.